Non-small cell lung cancer (NSCLC) specimens present a wide spectrum of oncogenic variants, ranging from DNA mutations to RNA fusions to exon skipping events
The broad and sensitive detection of these variants is typically challenged by both a limited amount of tumor tissue and technology-related workflow challenges. This white paper describes how the QuantideX DNA Hotspot 21 and RNA Lung Cancer Kits enable parallel detection of DNA- and RNA-associated variants in a comparatively simple workflow and on widely established laboratory equipment.
The QuantideX DNA Hotspot 21 and RNA Lung Cancer Kits are for research use only.
Offered Free by: Asuragen
See All Resources from: Asuragen